EUVIMED · CrossrefZeitschrift
npj Dementia
ISSN 3005-1940 · Springer Science and Business Media LLC
Neueste Artikel
Bridging the dementia diagnostic gap by addressing cognitive assessments globally
Data suggest a shift in the approach to Alzheimer’s disease prevention and treatment is warranted
Integrated manufacturing platform for cortical organoids reveals early phosphatase and prefoldin dysregulation in MAPT V337M neurons
Blood-based biomarkers of Alzheimer’s disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms
Ensuring access to Tau-Targeting therapies for MAPT frontotemporal dementia: patient community priorities for regulators and industry
The two faces of elderspeak
Brain age gradients as intermediate phenotypes linking plasma p-tau217 to cognition in community-dwelling older adults
External validation of dementia risk prediction models in the EPIC-Norfolk cohort: a UK-based cohort study
XPro1595 in early Alzheimer’s disease with inflammation: results from the phase 2 MINDFuL trial
The use of electroencephalography in neurodegenerative disease and its utility in dementia
“Micro-managing” immune activation and protein turnover: microglial lysosomes in the context of health and disease
Machine learning models for dementia risk prediction: evidence from the Sydney Memory and Ageing Study
Buntanetap treatment in mild to moderate Alzheimer’s disease: phase 2/3 study
Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation
Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer’s disease neuropathology
Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss
Plasma GFAP as a mediator and moderator of Aβ, tau, and neurodegeneration in Alzheimer’s disease
Plasma proteomic signatures associate with near-future Alzheimer’s disease dementia conversion in mild cognitive impairment patients
Association between gut microbial dysbiosis and Alzheimer’s disease: an umbrella review
Integrated genomic analysis and CRISPRi implicates EGFR in Alzheimer’s disease risk
COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years
Experience sampling in dementia: feasibility, utility and methodological insights from a high-intensity smartphone-based study
Sleep disturbances as risk factors for neurodegeneration later in life
Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration
Oral microbiome brain axis and cognitive performance in older adults
Alzheimer’s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer’s disease (ART-AD)
npj Dementia: Transformative research, global perspectives
Phosphodiesterase‑5 inhibitors and Alzheimer’s disease; a meta‑analysis on clinical studies
Investigating causal networks of dementia using causal discovery and natural language processing models
EUVIMED